Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive, and eating disorders.

Opiant CEO Roger Crystal on WSJ’s “Lunch Break”

September 15, 2016 – Opiant CEO Dr. Roger Crystal explains to The Wall Street Journal how Narcan Nasal Spray has been used to fight against opioid overdoses on the front line.

Opiant CEO Roger Crystal Shares Expertise on Treating Substance Abuse on NPR’s “BioTech Nation”

August 4, 2016 – With high-profile cases of opioid addiction in the headlines, Opiant Pharmaceuticals’ CEO, Dr. Roger Crystal, was a guest on NPR’s “BioTech Nation” program, hosted by Dr. Moira Gunn. During the interview, Dr. Crystal discussed Opiant’s NARCAN (naloxone HCl) Nasal Spray and the addiction treatment products that Opiant is developing for cocaine use disorder and binge eating disorder.

The interview was recorded at the International Biotechnology Conference, BIO 2016,in San Francisco. It aired on public radio stations nationwide. “BioTechNation” is also heard six times per week nationally on the Sirius-XM Radio channels, NPR Talk and NPR Now.

Latest News